‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal

‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal
Rewind to 2013. Ebos’s chief executive, Mark Waller (right), and Symbion’s chief executive, Patrick Davies, come together to mark a $1.1b transaction. (Image: NZME)
Rebecca Stevenson
In 2013, listed health and animal care company Ebos swallowed a giant. In June of that year, Ebos shareholders overwhelmingly voted for a $1.1 billion acquisition of pharmaceutical company Symbion, or Zuellig Healthcare Holdings Australia. This deal gave rise to a tagline Ebos still references today, as the largest diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It made Ebos then the third-largest listed company on the NZX, and a dual listing on the ASX followed la...

More Markets

NZ sharemarket edges higher as F&P Healthcare weighs on gains
Markets Market Close

NZ sharemarket edges higher as F&P Healthcare weighs on gains

The S&P/NZX 50 Index closed 14.49 points or 0.11% down at 13,391.59.

Jamie Gray 24 Oct 2025
Contact Energy expands global investor base
Markets

Contact Energy expands global investor base

Contact Energy priced an inaugural €500 million (NZ$1.01b) 7-year senior bond under its Euro Medium Term Note (EMTN) Programme, it said Friday.“This marks a milestone in Contact’s funding strategy, expanding our global investor base and reinforcing our commitment to sustainable f...

Rebecca Howard 24 Oct 2025
Kiwibank wary of capital-review barrier to growth
Finance

Kiwibank wary of capital-review barrier to growth

Kiwibank raises issues of competitive advantage.

Andy Macdonald 24 Oct 2025
Fonterra windfall brings risks: ASB
Primary Sector

Fonterra windfall brings risks: ASB

Farmers will vote for the Lactalis deal on Oct 30.

Rebecca Howard 24 Oct 2025